Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38

Joint Bone Spine

Volumn 80, Issue 5, 2013, Pages 449-453

  Clavel, Gaëlle ^a,b   Thiolat, Allan ^a   Boissier, Marie Christophe ^a,c  

^a UNIVERSITÉ PARIS 13   (France)

^b FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

IL 34; IL 35; IL 36; IL 37; IL 38; Interleukins; Rheumatoid arthritis

Indexed keywords

CYTOKINE; INTERLEUKIN 34; INTERLEUKIN 35; INTERLEUKIN 36; INTERLEUKIN 36 RECEPTOR; INTERLEUKIN 36 RECEPTOR ALPHA; INTERLEUKIN 37; INTERLEUKIN 38; INTERLEUKIN RECEPTOR; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; BONE DESTRUCTION; CELL ACTIVATION; CELL PROLIFERATION; CHRONIC INFLAMMATION; CYTOKINE RELEASE; HUMAN; NONHUMAN; OSTEOCLAST; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PSORIASIS; PSORIATIC ARTHRITIS; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SHORT SURVEY; SIGNAL TRANSDUCTION; TH17 CELL;

IL-34; IL-35; IL-36; IL-37; IL-38; INTERLEUKINS; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; HUMANS; INFLAMMATION; INTERLEUKINS; OSTEOCLASTS; T-LYMPHOCYTES, REGULATORY;

EID: 84885922086     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.04.014     Document Type: Short Survey

References (51)

1. Lin H., Lee E., Hestir K., et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008, 320:807-811.
2. Eda H., Zhang J., Keith R.H., et al. Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood. Cytokine 2010, 52:215-220.
3. Chen Z., Buki K., Vääräniemi J., et al. The critical role of IL-34 in osteoclastogenesis. PloS one 2011, 6:e18689.
4. Baud'huin M., Renault R., Charrier C., et al. Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. J Pathol 2010, 221:77-86.
5. Hwang S.-J., Choi B., Kang S.-S., et al. Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis. Arthritis Res Ther 2012, 14:R14.
6. Chemel M., Le Goff B., Brion R., et al. Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Ann Rheum Dis 2012, 71:150-154.
7. Niedbala W., Wei X.-Q., Cai B., et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007, 37:3021-3029.
8. Collison L.W., Delgoffe G.M., Guy C.S., et al. The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol 2012, 13:290-299.
9. Pope R.M., Shahrara S. Possible roles of IL-12-family cytokines in rheumatoid arthritis. Nat Rev Rheumatol 2013, 9:252-256.
10. Banchereau J., Pascual V., O'Garra A. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol 2012, 13:925-931.
11. Collison L.W., Workman C.J., Kuo T.T., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.
12. Collison L.W., Vignali D.A. Interleukin-35: odd one out or part of the family?. Immunol Rev 2008, 226:248-262.
13. Bettini M., Vignali D.A. Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 2009, 21:612-618.
14. Astry B., Harberts E., Moudgil K.D. A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis. J Interferon Cytokine Res 2011, 31:927-940.
15. Pillai M.R., Collison L.W., Wang X., et al. The plasticity of regulatory T cell function. J Immunol 2011, 187:4987-4997.
16. Collison L.W., Pillai M.R., Chaturvedi V., et al. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol 2009, 182:6121-6128.
17. Kochetkova I., Golden S., Holderness K., et al. IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J Immunol 2010, 184:7144-7153.
18. Wirtz S., Billmeier U., Mchedlidze T., et al. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 2011, 141:1875-1886.
19. Zandian M., Mott K.R., Allen S.J., et al. Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2. Gene Ther 2011, 18:734-742.
20. Huang C.-H., Loo E.X.-L., Kuo I.-C., et al. Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol 2011, 187:462-471.
21. Whitehead G.S., Wilson R.H., Nakano K., et al. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol 2012, 129:207-215. [e1-5].
22. Bardel E., Larousserie F., Charlot-Rabiega P., et al. Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35. J Immunol 2008, 181:6898-6905.
23. Allan S.E., Song-Zhao G.X., Abraham T., et al. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur J Immunol 2008, 38:3282-3289.
24. Chaturvedi V., Collison L.W., Guy C.S., et al. Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 2011, 186:6661-6666.
25. Collison L.W., Chaturvedi V., Henderson A.L., et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 2010, 11:1093-1101.
26. Sims J.E., Smith D.E. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010, 10:89-102.
27. Dunn E., Sims J.E., Nicklin M.J., et al. Annotating genes with potential roles in the immune system: six new members of the IL-1 family. Trends Immunol 2001, 22:533-536.
28. Towne J.E., Renshaw B.R., Douangpanya J., et al. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity. J Biol Chem 2011, 286:42594-42602.
29. Nicklin M.J.H. Finally, function for "IL-1Fs". Blood 2011, 118:5713-5714.
30. Vigne S., Palmer G., Lamacchia C., et al. IL-36R ligands are potent regulators of dendritic and T cells. Blood 2011, 118:5813-5823.
31. Blumberg H., Dinh H., Trueblood E.S., et al. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med 2007, 204:2603-2614.
32. Blumberg H., Dinh H., Dean C., et al. IL-1RL2 and its ligands contribute to the cytokine network in psoriasis. J Immunol 2010, 185:4354-4362.
33. Marrakchi S., Guigue P., Renshaw B.R., et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 2011, 365:620-628.
34. Onoufriadis A., Simpson M.A., Pink A.E., et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Gen 2011, 89:432-437.
35. Towne J.E., Sims J.E. IL-36 in psoriasis. Curr Opin Pharmacol 2012, 12:486-490.
36. Frey S., Derer A., Messbacher M.E., et al. The novel cytokine interleukin-36α is expressed in psoriatic and rheumatoid arthritis synovium. Ann Rheum Dis 2013, 10.1136/annrheumdis-2012-202264.
37. Magne D., Palmer G., Barton J.L., et al. The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes. Arthritis Res Ther 2006, 8:R80.
38. Tete S., Tripodi D., Rosati M., et al. IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation. Int J Immunopathol Pharmacol 2012, 25:31-38.
39. Wittmann M., Kingsbury S.R., McDermott M.F. Is caspase 1 central to activation of interleukin-1?. Joint Bone Spine 2011, 78:327-330.
40. Boraschi D., Lucchesi D., Hainzl S., et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 2011, 22:127-147.
41. Nold M.F., Nold-Petry C.A., Zepp J.A., et al. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 2010, 11:1014-1022.
42. Sharma S., Kulk N., Nold M.F., et al. The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 2008, 180:5477-5482.
43. McNamee E.N., Masterson J.C., Jedlicka P., et al. Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci U S A 2011, 108:16711-16716.
44. Bulau A.-M., Fink M., Maucksch C., et al. In vivo expression of interleukin-37 reduces local and systemic inflammation in concanavalin A-induced hepatitis. ScientificWorldJournal 2011, 11:2480-2490.
45. Song L., Qiu F., Fan Y., et al. Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus. J Clin Immunol 2013, 33:111-117.
46. Lin H., Ho A.S., Haley-Vicente D., et al. Cloning and characterization of IL-1HY2, a novel interleukin-1 family member. J Biol Chem 2001, 276:20597-20602.
47. Bensen J.T., Dawson P.A., Mychaleckyj J.C., et al. Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14. J Interferon Cytokine Res 2001, 21:899-904.
48. Lea W.-I., Lee Y.H. The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis. Joint Bone Spine 2012, 79:370-374.
49. Van de Veerdonk F.L., Stoeckman A.K., Wu G., et al. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc Natl Acad Sci U S A 2012, 109:3001-3005.
50. Rahman P., Sun S., Peddle L., et al. Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis Rheum 2006, 54:2321-2325.
51. Boissier M.-C Cell and cytokine imbalances in rheumatoid synovitis. Joint Bone Spine 2011, 78:230-234.